Investment Objective
The investment seeks to provide a tax-efficient investment return consisting of long-term capital appreciation.
The fund purchases stocks included in the FTSE Developed ex North America Index, which includes approximately 1,385 common stocks of companies located in developed countries of Europe, Australia, Asia, and the Far East. It uses statistical methods to "sample" the index, aiming to closely track its investment performance while limiting investments in Index securities that have undesirable tax characteristics in an attempt to minimize taxable income distributions.
Latest VEA News
No recent news for Vanguard FTSE Developed Markets ETF.
Performance
| 1 month | -4.62% | | 3 years | +11.54% |
| 3 months | +0.96% | | 5 years | -1.72% |
| 1 year | +30.96% | | Since inception | -2.22% |
Quote Details
| Previous close | $36.68 |
| Open day’s range | 36.51 – 36.92 |
| Net asset value (NAV) | 36.78 (06/05/2013) |
| Daily volume | 3,508,714 |
| Average volume (3 months) | 2,941,512 |
Data as of 4:00pm ET, 06/06/2013
Peer Comparisonvs. Foreign large blend ETFs
| | VEA | Category |
|---|
| Performance 5-yr return | -1.72% | -0.28% |
| Expense Gross exp ratio | 0.10% | 0.43% |
| Risk 5 year sharpe ratio | 0.05 | 0.07 |
| Net assets | $15.4B | $3.5B |
| Average market cap | $32.8B | $35.1B |
| Average P/E | 13.2 | 13.9 |
| Dividend / Share | -- | 0.47% |
Competitors
| EFA iShares MSCI EAFE Index Fund |
| SCHF Schwab International Equity ETF |
| GWL SPDR S&P World ex-US ETF |
Holdings
Top 5 Sectors
Portfolio weighting
Top 10 Holdings
Portfolio weighting
| -- Nestle SA | 2.03% |
| -- HSBC Holdings PLC | 1.69% |
| -- Novartis AG | 1.43% |
| -- Roche Holding AG | 1.43% |
| -- Toyota Motor Corp | 1.24% |
| -- Vodafone Group PLC | 1.21% |
| -- BP PLC | 1.17% |
| -- Sanofi | 1.06% |
| -- Royal Dutch Shell PLC Class A | 1.05% |
| -- GlaxoSmithKline PLC | 1.01% |
+0.21 / +0.57%
0.00 / 0.00%
.
